Effect of Intradiscal Methylene Blue Injection for the Chronic Discogenic Low Back Pain: One Year Prospective Follow-up Study (2012)

Peer-Reviewed Study · Kim SH, Ahn SH, Cho YW, et al. · October 31, 2012

Kim SH et al., 2012-10-31: Prospective one-year follow-up of 20 patients finding short-term pain relief after intradiscal methylene blue but maintenance in only 20% at 12 months. Cuts against the "long term" reading.

Successful outcome was maintained in only 5 patients (20%) for 1 year. The intradiscal MB injection is a short-term effective

Kim SH et al., 2012-10-31: Prospective one-year follow-up of 20 patients finding short-term pain relief after intradiscal methylene blue but maintenance in only 20% at 12 months. Cuts against the "long term" reading. Study type: prospective single-arm follow-up study. N=20. Country: Korea. Intradiscal MB; dose not in abstract; single injection; 12-month follow-up. Funding/conflicts: not stated. Comparator: baseline. 55% success at 3 months, 20% at 12 months; pain relapsed in 6 of 11 early responders. Study type: uncontrolled series.